Simple Summary Medulloblastoma is the most common pediatric brain tumor, comprising
one-third of all pediatric brain tumors, and originating in the posterior fossa of the brain. The …

Medulloblastoma (MB) is the most common malignant childhood tumor of the brain.
Multimodal treatment consisting of surgery, radiation therapy, and chemotherapy reduced …

Medulloblastoma is a malignant tumor of the cerebellum and the most frequent malignant
brain tumor in children. The standard of care consists of maximal resection surgery, followed …

Background Conventional parameters show limited and unreliable correlations with
medulloblastoma prognosis. Aim To evaluate the factors influencing overall survival (OS) …

Purpose We aimed to compare treatment results in and outside of a randomized trial and to
confirm factors influencing outcome in a large retrospective cohort of nonmetastatic …

Abstract Purpose of Review Molecular subtyping in medulloblastoma (MB) has diagnostic
and prognostic values which impact therapy. This paper provides guidance for the clinician …

Objective Persistent hydrocephalus following posterior fossa brain tumor (PFBT) resection is
a common cause of morbidity in pediatric brain tumor patients, for which the optimal …

Purpose The extent to which racial/ethnic brain tumour survival disparities vary by age is not
very clear. In this study, we assess racial/ethnic brain tumour survival disparities overall by …

Abstract Introduction Hydrocephalus persists in 10–40% of children with posterior fossa
tumours (PFT). A delay in commencement of adjuvant therapy (AT) can negatively influence …

Purpose Patient travel time can cause treatment delays when providers and families decide
to seek proton therapy. We examined whether travel distance or referral pattern (domestic …